Characterization of a novel prostate cancer factor contactin 1 (CNTN1)-derived tumorigenesis through establishing a new transgenic mouse model for prostate cancer
Characterization of a novel prostate cancer factor contactin 1 (CNTN1)-derived tumorigenesis through establishing a new transgenic mouse model for prostate cancer
批准号:
488928
负责人:
Tang Damu
金额:
$61.02万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2023
资助国家:
加拿大
项目状态:
未结题
起止时间:
2023-09-01 至 2028-09-01
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Prostate cancer (PC) affects one in six men and is the second leading cause of cancer-associated deaths in Canadian men. Mortality is caused by cancer progression.
A major progression is recurrence following initial therapy. Recurrent PCs have higher ris
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
PCSK9, a novel contributor to the development of castration resistant prostate cancer
-
批准号:389512
-
项目类别:Operating Grants
-
资助金额:$42.08万
-
财政年份:2018
-
负责人:Tang Damu
-
依托单位:
Investigation of Shank-interacting protein-like 1 (SIPL1)-mediated PTEN inactivation during breast tumorigenesis
-
批准号:207777
-
项目类别:Operating Grants
-
资助金额:$27.27万
-
财政年份:2010
-
负责人:Tang Damu
-
依托单位:
Characterization of AKF-PD-mediated protection of diabetic nephropathy in db/db mice
-
批准号:203977
-
项目类别:Operating Grants
-
资助金额:$10.45万
-
财政年份:2010
-
负责人:Tang Damu
-
依托单位:
Investigation of Shank-interacting protein-like 1 (SIPL1)-mediated PTEN inactivation during breast tumorigenesis
-
批准号:205080
-
项目类别:Operating Grants
-
资助金额:$7.29万
-
财政年份:2009
-
负责人:Tang Damu
-
依托单位:
海外基金